Kronos Bio, Inc. is a clinical development biopharmaceutical company. It engages in the business of developing therapeutics that target dysregulated transcription that causes cancer and other serious diseases. The company was founded by Arie S. Belldegrun, Joshua A. Kazam, David M. Tanen, and Christopher Wilfong on June 2, 2017 and is headquartered in San Ma...
Institut Català d'Oncologia - Hospital Duran i Reynals (ICO L'Hospitalet), Barcelona, Spain
The Blood and Marrow Transplant Group of Georgia, Atlanta, Georgia, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Mount Sinai Health System, New York, New York, United States
Hôpital Côte De Nacre, Caen, Calvados, France
Hollings Cancer Center, Charleston, South Carolina, United States
O'Neal Comprehensive Cancer Center at the University of Alabama, Birmingham, Alabama, United States
City of Hope, Duarte, California, United States
MemorialCare - Orange Coast Medical Center, Fountain Valley, California, United States